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report  <ArtRef doi=”10.1083/j cb.200703209”>Willis et al. </ArtRef> 
Unique sets of mRNAs, 
the ﬁ   ndings show, are 
brought to or warded 
off from axon sites in 
contact with neuronal 
growth factors.
Axons have their 
own translational ma-
chinery that allows them 
to respond to stimuli 
rapidly. Stores of tran-
scripts lie in wait near 
axonal ribosomes, ready 
to be translated when called upon. The make-up of these stores, the 
new results reveal, can be changed locally by extracellular cues.
To measure store changes, the group ﬁ  rst took an inven-
tory of messages that are translated in injured axons, which 
ramp up local protein synthesis. Using this baseline, the authors 
then calculated transcript changes at sites also exposed to 
extracellular growth factors.
Growth-promoting neurotrophins caused some nearby 
transcript levels to increase and others to decrease. Growth 
inhibitors such as myelin-associated glycoprotein often had the 
opposite effects on those same transcripts.
Not all mRNAs were affected equally by growth promoters. 
The GAP43 transcript was attracted by NGF but not BDNF. And 
the necessary signaling pathways also differed. Trk neurotrophin re-
ceptors were commonly required, but only some transcript changes 
also required either or both PI3K and MAP kinase signaling.
The attraction of messages by neurotrophins required 
transport along microtubules both back to the cell body and out 
to the axon. This messaging system probably tells the cell body to 
send out the necessary new recruits. Indeed, levels of speciﬁ  c 
transcripts in the cell body dropped as they increased in the axon.
Changes in transcripts that were repulsed by growth 
inhibitors did not require microtubule transport back to the 
body. These axonal transcripts might be either degraded, sent 
further out into the axon, or transported along actin instead.
In addition to neurons, ﬁ  broblasts and muscle cells also 
locally translate speciﬁ  c messages. Although isolating small 
areas of their cytoplasm would be difﬁ  cult, these and other 
cell types probably also change transcript stores in response 
to extracellular cues. 
Reference: Willis, D.E., et al. 2007. J. Cell Biol. 178:965–980.
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T
he motor that puts a brake on 
spindle microtubule sliding also 
decelerates axon branching, report 
<ArtRef doi=”10.1083/jcb.200702074”>Myers and Baas </ArtRef>.
The spindle brake is kinesin-5. Unlike 
most microtubule-based motors, the “cargo” 
of kinesin-5 is more microtubules. In di-
viding cells, this motor bundles oppositely 
oriented spindle microtubules and seems to 
help drive them apart. Recent work shows 
that kinesin-5 can also prevent them from 
sliding past each other too quickly, thus 
preventing premature pole separation.
Kinesin-5 also has a strong presence 
in developing neurons, which are done 
dividing and would thus seem not to need 
a spindle brake. Because its inhibition 
creates longer axons, Myers and Baas 
imagined that kinesin-5 normally trans-
ports short microtubule building blocks 
from the axon back to the cell body. In its 
absence, they fi  gured, more blocks would 
be available for axon growth.
Instead, the authors found that short 
microtubules were transported twice as 
frequently without kinesin-5, both into and 
out of axons. The increase in transport and 
axon length was accompanied by an increase 
in axon branching. Normally, axons send out 
many new branches, most of which collapse 
back into the growth cone. But these retrac-
tion events were rare without kinesin-5.
Retraction is a result of myosin-2’s 
pulling force on the actin cytoskeleton. 
Dynein can counteract this force by hook-
ing actin to long structural support micro-
tubules. The authors now hypothesize that 
kinesin-5 opposes dynein, thus allowing 
retraction to occur. They suggest that it 
might do so by physically replacing dynein 
or by bundling microtubules, thereby in-
creasing dynein’s load.
Drugs that block kinesin-5 activity are 
already in use as cancer therapies, thanks 
to their antimitotic effects. If kinesin-5 is 
also expressed in adult axons, the drugs 
might fi  nd secondary uses in prodding the 
regeneration of damaged axons. 
Reference: Myers, K.A., and P.W. Baas. 
2007. J. Cell Biol. 178:1081–1091.
Axons branch wildly without kinesin-5 (bottom).
A bead of NGF (gray) attracts high levels 
(red) of 𝗃-actin mRNA.